Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Oligodeoxynucleotides decoy

Tomita N, Azuma H, Kaneda Y, Ogihara T, Morishita R (2004) Application of decoy oligodeoxynucleotides-based approach to renal diseases. Curr Drug Targets 5 717-733... [Pg.19]

Kubo, T., Kinjyo, N., Ikezawa, A., et al. 2003. Spl decoy oligodeoxynucleotide decreases angiotensin receptor expression and blood pressure in spontaneously hypertensive rats. Brain Res 992 1-8. [Pg.111]

Morishita R, Aoki M, Kaneda Y (2001) Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease. Ann NY Acad Sci 947 294-301... [Pg.86]

Therapeutic Decoy ODN Application 233 Table 9.1 Potential therapeutic benefits of decoy oligodeoxynucleotides (ODNs). [Pg.244]

Ahn JD, Morishita R, Kaneda Y, et al. Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo. Circ Res 2002 90 1325-1332. [Pg.164]

Development and Modification of Decoy Oligodeoxynucleotides for Clinical Application... [Pg.49]

Keywords Bone disease, Cardiovascular disease. Decoy oligodeoxynucleotide, NF-kB... [Pg.50]

Osako MK, Tomita N et al (2007) Increase in nuclease resistance and incorporation of NF-kappaB decoy oligodeoxynucleotides by modification of the 3 -terminus. J Gene Med 9(9) 812-819... [Pg.59]

Miyake T, Aoki M et al (2006) Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model. J Mol Cell Cardiol 41(3) 431 140... [Pg.59]

Egashira K, Suzuki J et al (2008) Long-term follow up of initial clinical cases with NF-kappaB decoy oligodeoxynucleotide transfection at the site of coronary stenting. J Gene Med 10(7) 805-809... [Pg.59]

Kunugiza Y, Tomita T et al (2006) Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo. Arthritis Res Ther 8(4) R103... [Pg.59]

Shimizu H, Nakagami H et al (2006) NFkappaB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoelasts. Gate Ther 13(12) 933-941... [Pg.59]

See other pages where Oligodeoxynucleotides decoy is mentioned: [Pg.364]    [Pg.77]    [Pg.79]    [Pg.84]    [Pg.493]    [Pg.499]    [Pg.240]    [Pg.323]    [Pg.1851]    [Pg.1852]    [Pg.49]    [Pg.50]    [Pg.50]    [Pg.50]   
See also in sourсe #XX -- [ Pg.49 ]



SEARCH



Decoy

Decoy oligodeoxynucleotide

Decoy oligodeoxynucleotide

Oligodeoxynucleotide

Oligodeoxynucleotides

© 2024 chempedia.info